Omar Iskanderani

Dr. Omar Iskanderani

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2022 in Cureus
Verified
Journal Article
Open access
ASAli A Samkari
Ali A Samkari
MAMeaad Alsulami
Meaad Alsulami
LBLinah Abdullah Bataweel
Linah Abdullah Bataweel
RARozan Altaifi
Rozan Altaifi
AAAhmed Altaifi
Ahmed Altaifi
NTNora H. Trabulsi
Nora H. Trabulsi
Breast cancer is the most frequent type of cancer as well as one of the main causes of cancer-related mortality in women. Human microbial dysbiosis, which has been related to a range of malignancies, is one of the variables that may impact the chance of developing breast disorders. In this review, we aimed to investigate the relationship between breast cancer and benign breast tumors with dysbiosis of the microbiome at different body sites. We performed a systematic review of MEDLINE, Scopus, Ovid, and Cochrane Library to identify original articles published until July 2020 that reported studies of breast disease and microbiota. Twenty-four original articles were included in the study, which looked at the features and changes in breast, gut, urine, lymph node, and sputum microbial diversity in patients with benign and malignant breast tumors. In breast cancer, the breast tissue microbiome demonstrated changes in terms of bacterial load and diversity; in benign breast tumors, the microbiome was more similar to a malignant tumor than to normal breast tissue. Triple-negative (TNBC) and triple-positive (TPBC) types of breast cancer have a distinct microbial pattern. Moreover, in breast cancer, gut microbiota displayed changes in the compositional abundance of some bacterial families and microbial metabolites synthesis. Our review concludes that breast carcinogenesis seems to be associated with microbial dysbiosis. This information can be further explored in larger-scale studies to guide new prophylactic, diagnostic, and therapeutic measures for breast cancer.

8 June 2021 in Cureus
Verified
Journal Article
Open access
NTNora H. Trabulsi
Nora H. Trabulsi
ASAlaa A Shabkah
Alaa A Shabkah
RUReem Ujaimi
Reem Ujaimi
OIOmar Iskanderani
Omar Iskanderani
MKMai S. Kadi
Mai S. Kadi
ASAli A Samkari
Ali A Samkari
Breast cancer (BC) is the most common cancer in the Kingdom of Saudi Arabia (KSA) and the second leading cause of cancer-related mortality. About 40% of BC in KSA is locally advanced BC (LABC), which has been associated with poorer survival compared with early diagnosed BC. To review the presentation and outcomes of LABC, including the characteristics of the disease, different treatment modalities, overall survival (OS), disease-free survival (DFS), and local recurrence in relation to different radiotherapy (RT) techniques. We retrospectively reviewed the medical records of 153 female patients with pathologically proven LABC diagnosed at King Abdulaziz University Hospital, Jeddah, KSA, between 2009 and 2017. We obtained data on patient demographics, stage of cancer at diagnosis, tumor characteristics (subtype and receptor status), type of surgery, systemic treatments received (hormonal, targeted therapy, and chemotherapy), RT variables, and recurrence and death dates. Data were analyzed to assess OS and DFS by using Kaplan-Meier analyses and the log-rank test. Univariate and multivariate Cox proportional hazard regression analyses were used to explore and identify factors associated with survival. The median survival time in the study population was 9.16 years. Older age (65+ years) was associated with worse OS and DFS than was younger age (<65 years) (hazard ratio (HR) 3.20, 95% CI 1.48-6.90, P = 0.003 and HR 2.21, 95% CI 1.12-4.36, P = 0.022, respectively). Regarding the type of surgery, having a mastectomy was associated with worse OS and DFS than was having a lumpectomy (HR 2.44, 95% CI 0.97-6.12, P = 0.05 and HR 2.41, 95% CI 1.13-5.14, P = 0.023, respectively). Positive estrogen and progesterone receptor status was associated with better OS and DFS than was a negative estrogen or progesterone receptor status (HR 0.13, 95% CI 0.05-0.30, P < 0.001 and HR 0.21, 95% CI 0.11-0.41, P < 0.001, respectively). Patients who received RT had a lower risk of recurrence than did those who did not receive RT (P = 0.011). Moreover, three-dimensional conformal RT was associated with lower local recurrence than intensity-modulated RT or volumetric-modulated arc therapy (P = 0.003). Multiple factors can affect the OS and DFS in LABC. Younger patients, having hormone-positive disease, and undergoing lumpectomy were associated with better outcomes. Adjuvant RT may improve local control and the use of three-dimensional conformal RT was superior for local control. Prospective studies with larger sample sizes are needed to further highlight these findings and to assess the role of chemotherapy and targeted therapy in patients with LABC.

1 January 2021 in Advances in Radiation Oncology
Verified
Journal Article
Open access
ZMZaheeda Mulla
Zaheeda Mulla
OIOmar Iskanderani
Omar Iskanderani
AWAmina Weber
Amina Weber
AAAbdullah AlMohamad
Abdullah AlMohamad
MAMohammed Sheikh Al-Amoodi
Mohammed Sheikh Al-Amoodi
SSSHAMEL MOHAMED SOAIDA
SHAMEL MOHAMED SOAIDA
This study aimed to compare thermoplastic mask with bra in terms of setup reproducibility and immobilization of pendulous breasts during radiation therapy (RT). Forty-two female patients with breast cancer treated with either intensity modulated RT or 3-dimensional conformal RT were retrospectively reviewed. Of these, 21 benefited from thermoplastic mask immobilization and 21 used a bra. Setup accuracy was evaluated using consecutive cone beam computed tomography/electronic portal imaging device sessions over the first 3 days before treatment (systematic setting), followed by weekly cone beam computed tomography/electronic portal imaging device (random settings), and compared with the reference image to calculate the corresponding translational shift (setup error) in the 3 planes. Average absolute shift values in both systematic and random settings were compared between the 2 groups. Accuracy was analyzed by comparing the percentage of pooled settings within ±0.05 and ±0.1 cm of the reference image. Compared with a bra, use of the mask was associated with a smaller longitudinal shift in systematic settings (difference in mean: 0.27 cm; P = .027; Mann-Whitney U test) and a lesser lateral shift in random setting (difference in mean: 0.19 cm; P = .005; Mann-Whitney U test). In the pooled systematic settings, the mask performed relatively better than the bra in the lateral and longitudinal planes, with no statistical significance. In pooled random settings, mask showed greater accuracy than bra in the lateral plane with 86.0% versus 58.9% accuracy at ±0.5 cm (P < .001) and 48.8% versus 21.7% accuracy at ±0.1 cm (P < .001), respectively. There was no significant difference in the incidence of radiodermatitis between the 2 groups. However, a hypofractionation regimen was associated with a lower incidence of radiodermatitis, and the severity of skin reactions was positively correlated with treatment dose (unstandardized regression coefficient: B = .001; correlation coefficient: r = .571; P < .001). Masks provide superior reproducibility compared with commercially available bras.

21 August 2018 in Cancer Therapy & Oncology International Journal
Verified
Journal Article
Open access
PDF file
OIOmar Iskanderani
Omar Iskanderani
HPrimary central nervous system lymphoma (PCNSL) is an uncommon malignant syndrome, appearing more frequently with old ages patients. In the last decade, serious modifications in the treatments approaches were done. This is a retrospective review to asses these modifications in our practice and their effect on prognosis over a 17-year time period. We reviewed the patient radiological data and histopathology of all patients diagnosed with this disease (according to the neuropathological registry) at Toulouse University Hospital and Institut Claudius Regaud between 1995–2012. 78 patients were included (44 females, 34 males) with Karnofsky Performance Status (KPS) score of median 80%. The patient age groups ranged between (25–86 years) and the rate of overall survival was 23.1 months. Within routine practice, we observed modifications in the therapeutic strategy for this disease in the last decade and improvements in the dealing with managements; the treatment used in the medical oncology spicily in chemotherapy were changed, and radiotherapy is not common used as first-choice treatment. This study from our data, emphasizing the need for a prospective study investigating therapeutic strategies for this kind of disease (PCNSL), especially in elderly patients.

26 March 2017 in Cureus
Verified
Journal Article
Open access
PDF file
OIOmar Iskanderani
Omar Iskanderani
DRDavid Roberge
David Roberge
GCGeneviève Coulombe
Geneviève Coulombe
Thymic carcinoid tumors are very rare. Between two and four percent of carcinoids originate from the thymus with an estimated incidence of 1.5 to 3 per 10,000,000 persons per year. Thymic carcinoids can be associated with the multiple endocrine neoplasia (MEN) type 1. The principal treatment is surgical resection. The potential roles of systemic and radiation treatments are a matter of debate. We describe the successful multidisciplinary treatment of a case of thymic carcinoid associated with MEN and review the literature pertaining to the use of adjuvant thoracic radiation.